Molson Coors is trimming the number of items it sells and moving in the direction of more premium items.
Latest posts by Market Watch (see all)
- Pfizer and BioNTech submit initial data to FDA from trial of COVID-19 vaccine in children aged 5 to 12 - September 28, 2021
- Gogo shares jump 6% premarket after company raises long-term financial targets - September 28, 2021
- Eli Lilly says it will reduce insulin list prices to 2008 levels - September 28, 2021